# FDA 483 - Ritsa Pharma Private Limited - September 05, 2025

Source: https://www.keypedia.com/records/483/ritsa-pharma-private-limited/d8656428-fa5a-48ce-b5f8-2fe6abc5247e

> FDA 483 for Ritsa Pharma Private Limited on September 05, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ritsa Pharma Private Limited
- Inspection Date: 2025-09-05
- Product Type: drugs
- Office Name: Office of Partnerships
- Summary: An FDA inspection of Ritsa Pharma Private Limited in Medchal Malkajgiri, India, revealed deficiencies in their materials system. The firm failed to establish the reliability of component suppliers and did not conduct appropriate testing to ensure the quality, purity, and strength of received components. This included not validating supplier COAs and inadequate material sampling methods.

## Related Officers

- [Pearl C. Ozuruigbo](https://www.keypedia.com/people/pearl-c-ozuruigbo/28ec383e-a602-4764-8d14-20b1049f93d7)

Company: https://www.keypedia.com/companies/ritsa-pharma-private-limited/f57c2448-1aed-4480-99f4-ae26bf8f6071

Office: https://www.keypedia.com/offices/office-of-partnerships/83acc701-fc5a-4876-bb34-7499e31541d3